Clinical Trials

100 enrolled

Epstein-Barr Virus Infections

NCT05644808 2026-05-18

MYLUNG

1,002 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05939128 2026-05-15

ERA

625 enrolled

Breast Neoplasms

NCT04136002 2026-05-14

ECLIPSE

44,467 enrolled

Colorectal Neoplasms

NCT05140369 2026-05-14

CLL registry

6,000 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05742217 2026-05-14

MUST

250 enrolled

Plasma cell

Multiple Myeloma

NCT06175637 2026-05-13

PEDIA

409 enrolled

CNS

Neurofibroma, Plexiform

NCT06117891 2026-05-12

REFINE-IO

300 enrolled

Unresectable Hepatocellular Carcinoma

NCT07567352 2026-05-12

A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment

200 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04122976 2026-05-11

DAROL

805 enrolled

Prostatic Neoplasms

NCT02808780 2026-05-08

OPAL

537 enrolled

Lymphoid

Colitis, Ulcerative, Lymphoma, Neoplasms

NCT05901649 2026-05-08

ArtemisPRO

504 enrolled

Metastatic Hormone-sensitive Prostate Cancer

NCT06269133 2026-05-08

Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients

1,000 enrolled

Advanced Non-small Cell Lung Cancer

NCT05954910 2026-05-01

A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

1,000 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06125795 2026-05-01

PROVIDENCE

146 enrolled

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Patient Preference

NCT03647878 2026-04-30

CABOCARE

224 enrolled

Carcinoma, Renal Cell

NCT04106349 2026-04-30

REPLICA

150 enrolled

Carcinoma, Renal Cell

NCT05117840 2026-04-30

SHIELD

12,000 enrolled

Lung Neoplasms

NCT05377684 2026-04-30

ROSE

450 enrolled

Breast Neoplasms

NCT05478538 2026-04-29

CYBRID-01

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05520099 2026-04-29

ELEPHAS-02

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

416 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05981131 2026-04-29

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

6 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06476665 2026-04-28

A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

10 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06555692 2026-04-28

SCderm

120 enrolled

Breast Cancer Female

NCT06004440 2026-04-24

Real World Registry for Use of the Ion Endoluminal System

1,301 enrolled

Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Multiple Pulmonary Nodules

NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

2,907 enrolled

Breast Neoplasms

NCT04759781 2026-04-23

MERLIN_001

1,820 enrolled

CNSDermatologic

Melanoma, Neurofibromatosis 2

NCT06205498 2026-04-23

ARISE

151 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06187103 2026-04-21

Evaluation of Improved Onboard Patient Imaging

BreastGastrointestinalGynecologicHead & NeckThoracic

40 enrolled

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Pelvic Neoplasms

NCT07541703 2026-04-21

Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

2,200 enrolled

Breast Neoplasms

NCT03729453 2026-04-20

Intra-operative Pancreatoscopy in Patients With IPMN

100 enrolled

Intraductal Papillary Mucinous Neoplasm

NCT02954094 2026-04-17

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

10,000 enrolled

Liver Neoplasms

NCT06010914 2026-04-15

DADOX

100 enrolled

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT02185560 2026-04-14

JPMS-DTC

453 enrolled

Head & Neck

Thyroid Neoplasms

NCT02394834 2026-04-13

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

757 enrolled

Colorectal Neoplasms

NCT04767594 2026-04-13

PERFORM

1,407 enrolled

Breast Neoplasms

NCT05735327 2026-04-13

ENTIRETY

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05872763 2026-04-13

A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery

1,200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06874114 2026-04-13

RE-ENGAGE

700 enrolled

Metastatic Hormone-sensitive Prostate Cancer

NCT07022457 2026-04-13

UK-EnBiRiM

50 enrolled

Dermatologic

Melanoma

NCT04911478 2026-04-09

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells